These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2024737)

  • 21. Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
    Andersen AD; Blaabjerg M; Binzer M; Kamal A; Thagesen H; Kjaer TW; Stenager E; Gramsbergen JBP
    J Neurochem; 2017 May; 141(4):614-625. PubMed ID: 28244186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY5Y cells, and the said effect is attenuated by metallothionein.
    Wanpen S; Govitrapong P; Shavali S; Sangchot P; Ebadi M
    Brain Res; 2004 Apr; 1005(1-2):67-76. PubMed ID: 15044066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transplantation of fetal adrenal medullary to the brain in Parkinson's disease].
    Ren B
    Zhonghua Wai Ke Za Zhi; 1992 Mar; 30(3):147-8, 189. PubMed ID: 1473383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease.
    Ahlskog JE; Tyce GM; Kelly PJ; van Heerden JA; Stoddard SL; Carmichael SW
    Exp Neurol; 1989 Aug; 105(2):152-61. PubMed ID: 2753115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.
    Eldrup E; Mogensen P; Jacobsen J; Pakkenberg H; Christensen NJ
    Acta Neurol Scand; 1995 Aug; 92(2):116-21. PubMed ID: 7484057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenal medullary transplants as a treatment for Parkinson's disease.
    Lieberman A; Ransohoff J; Berczeller P; Brous P; Eng K; Goldstein M; Kaufman B; Koslow M; Lieberman I
    Adv Neurol; 1990; 53():567-70. PubMed ID: 2239497
    [No Abstract]   [Full Text] [Related]  

  • 27. Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid.
    Maruyama W; Narabayashi H; Dostert P; Naoi M
    J Neural Transm (Vienna); 1996; 103(8-9):1069-76. PubMed ID: 9013394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease, and their changes after L-dopa administration.
    Tohgi H; Abe T; Takahashi S; Takahashi J; Hamato H
    Neurosci Lett; 1993 Sep; 159(1-2):135-8. PubMed ID: 7505410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenal neural transplants in Parkinson's disease.
    Koller WC; Waxman M; Morantz R
    Adv Neurol; 1990; 53():559-65. PubMed ID: 2239496
    [No Abstract]   [Full Text] [Related]  

  • 30. Dopamine/L-dopa ratio in cerebrospinal fluid of parkinsonian patients treated with L-dopa + benserazide.
    Fekete M; Tárczy M; Bihari K; Katona G
    Psychopharmacology (Berl); 1984; 82(1-2):93-4. PubMed ID: 6420835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concentrations of tyrosine, L-dihydroxyphenylalanine, dopamine, and 3-O-methyldopa in the cerebrospinal fluid of Parkinson's disease.
    Tohgi H; Abe T; Takahashi S; Nozaki Y; Kikuchi T
    Neurosci Lett; 1991 Jun; 127(2):212-4. PubMed ID: 1908962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-year follow-up study of a patient with Parkinson's disease and severe motor fluctuations treated by co-grafts of adrenal medulla and peripheral nerve into bilateral caudate nuclei: case report.
    Date I; Asari S; Ohmoto T
    Neurosurgery; 1995 Sep; 37(3):515-8; discussion 518-9. PubMed ID: 7501119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Grafting of perfused adrenal medullary tissue into the caudate nucleus of patients with Parkinson's disease. Clinica Puerta de Hierro Neural Transplantation Group.
    López-Lozano JJ; Bravo G; Abascal J
    J Neurosurg; 1991 Aug; 75(2):234-43. PubMed ID: 2072160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain.
    Antkiewicz-Michaluk L; Romañska I; Papla I; Michaluk J; Bakalarz M; Vetulani J; Krygowska-Wajs A; Szczudlik A
    Neuroscience; 2000; 96(1):59-64. PubMed ID: 10683410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Salsolinol, an endogenous molecule. Possible implications in alcoholism, Parkinson's disease and pain].
    Vernay D; Eschalier A; Durif F; Aumaitre O; Rigal B; Ben Sadoun A; Fialip J; Marty H; Philip E; Bougerolle AM
    Encephale; 1989; 15(6):511-6. PubMed ID: 2515055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of adrenal medullary tissue transplantation to striatum in parkinsonism.
    Jiao SS; Zhang WC; Cao JK; Zhang ZM; Wang H; Ding MC; Zhang Z; Sun JB; Sun YC; Shi MT
    Prog Brain Res; 1988; 78():575-80. PubMed ID: 3247452
    [No Abstract]   [Full Text] [Related]  

  • 37. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
    Naoi M; Maruyama W; Nagy GM
    Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments.
    Kurnik-Łucka M; Panula P; Bugajski A; Gil K
    Neurotox Res; 2018 Feb; 33(2):485-514. PubMed ID: 29063289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine-derived tetrahydroisoquinolines and Parkinson's disease.
    Dostert P; Strolin Benedetti M; Della Vedova F; Allievi C; La Croix R; Dordain G; Vernay D; Durif F
    Adv Neurol; 1993; 60():218-23. PubMed ID: 8420138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased vulnerability of parkin knock down PC12 cells to hydrogen peroxide toxicity: the role of salsolinol and NM-salsolinol.
    Su Y; Duan J; Ying Z; Hou Y; Zhang Y; Wang R; Deng Y
    Neuroscience; 2013 Mar; 233():72-85. PubMed ID: 23291452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.